Curol Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Andhra Pradesh, Telangana, India, established in 2003.
2003 Andhra Pradesh, Telangana, India Struck Off
Last Updated:
Access Report
About Curol Pharmaceuticals Private Limited

Curol Pharmaceuticals Private Limited, a struck off private limited company, was established on 13 November 2003 in Andhra Pradesh, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239TG2003PTC042054. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M.

Its leadership includes Narender Reddy Bheemreddy (Director). It holds no open charges and ₹0.47 M settled loans. It is based at H.No.1-5-62/10/A, Street No.8,V.V.Nagar, Hubsiguda Hyderabad-7., Andhra Pradesh, Telangana, 500007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2003PTC042054

  • Registration Number

    042054

  • Incorporation Date

    13 November 2003

  • Authorized Capital

    ₹0.50 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Company Age 22 Year, 6 Months
  • Satisfied Charges ₹ 0.47 M
Company report

Curol Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Curol Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Curol Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Narender Reddy Bheemreddy Director 13 Nov 2003 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Curol Pharmaceuticals.

Enhance accessibility to Curol Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Curol Pharmaceuticals revenue growth over time
Curol Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Curol Pharmaceuticals?

Unlock access to Curol Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹465,000.00

Charges Breakdown by Lending Institutions
  • A.P. State Finnacial Corporation : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
06 Jan 2006 A.P. State Finnacial Corporation ₹0.47 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Curol Pharmaceuticals?

Unlock and access historical data on people associated with Curol Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Curol Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curol Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Curol Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge registered on 06 Jan 2006 via Charge ID 90263022 with A.P. State Finnacial Corporation was fully satisfied on 08 Apr 2011. was recorded as a recent event.

  • Charges

    The activity A charge with A.P. State Finnacial Corporation amounted to Rs. 0.47 M with Charge ID 90263022 was registered on 06 Jan 2006. was completed.

  • Director Appointment

    Progress on Narender Reddy Bheemreddy was appointed as a Director was appointed as a Director on 13 Nov 2003 & has been associated with this company since 22 years 6 months . was documented.

  • Company Incorporation

    Progress on Curol Pharmaceuticals Private Limited was registered on 13 Nov 2003 with Roc Hyderabad & aged 22 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Curol Pharmaceuticals Private Limited?

The CIN of Curol Pharmaceuticals Private Limited is U24239TG2003PTC042054.

Where is Curol Pharmaceuticals Private Limited headquartered?

Curol Pharmaceuticals Private Limited is headquartered at H.No.1-5-62/10/A, Street No.8,V.V.Nagar, Hubsiguda Hyderabad-7., Andhra Pradesh, Telangana, 500007.

When was Curol Pharmaceuticals Private Limited incorporated?

Curol Pharmaceuticals Private Limited was incorporated on 13 November 2003.

Who are the current directors of Curol Pharmaceuticals Private Limited?

The current directors of Curol Pharmaceuticals Private Limited are

What is the primary industry of Curol Pharmaceuticals Private Limited?

The primary industry of Curol Pharmaceuticals Private Limited is Chemicals.

Is Curol Pharmaceuticals Private Limited a listed company?

Curol Pharmaceuticals Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available